Haemonetics Corp (HAE)
85.43
+0.51
(+0.60%)
USD |
NYSE |
Nov 21, 16:00
85.46
+0.04
(+0.04%)
Pre-Market: 20:00
Haemonetics Gross Profit Margin (Quarterly): 54.25% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 54.25% |
| June 30, 2024 | 52.03% |
| March 31, 2024 | 51.24% |
| December 31, 2023 | 52.90% |
| September 30, 2023 | 53.59% |
| June 30, 2023 | 53.73% |
| March 31, 2023 | 51.33% |
| December 31, 2022 | 51.98% |
| September 30, 2022 | 53.07% |
| June 30, 2022 | 54.41% |
| March 31, 2022 | 51.44% |
| December 31, 2021 | 53.34% |
| September 30, 2021 | 51.08% |
| June 30, 2021 | 47.30% |
| March 31, 2021 | 36.35% |
| December 31, 2020 | 50.03% |
| September 30, 2020 | 50.48% |
| June 30, 2020 | 46.03% |
| March 31, 2020 | 47.61% |
| December 31, 2019 | 49.45% |
| September 30, 2019 | 50.28% |
| June 30, 2019 | 48.61% |
| March 31, 2019 | 44.61% |
| December 31, 2018 | 44.95% |
| September 30, 2018 | 46.32% |
| Date | Value |
|---|---|
| June 30, 2018 | 36.30% |
| March 31, 2018 | 44.70% |
| December 31, 2017 | 47.55% |
| September 30, 2017 | 46.39% |
| June 30, 2017 | 43.45% |
| March 31, 2017 | 36.00% |
| December 31, 2016 | 44.36% |
| September 30, 2016 | 47.33% |
| June 30, 2016 | 43.37% |
| March 31, 2016 | 36.82% |
| December 31, 2015 | 46.64% |
| September 30, 2015 | 47.93% |
| June 30, 2015 | 48.05% |
| March 31, 2015 | 47.85% |
| December 31, 2014 | 48.17% |
| September 30, 2014 | 47.51% |
| June 30, 2014 | 47.34% |
| March 31, 2014 | 47.88% |
| December 31, 2013 | 50.24% |
| September 30, 2013 | 50.85% |
| June 30, 2013 | 50.75% |
| March 31, 2013 | 49.27% |
| December 31, 2012 | 45.72% |
| September 30, 2012 | 46.64% |
| June 30, 2012 | 51.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.35%
Minimum
Mar 2021
54.41%
Maximum
Jun 2022
50.58%
Average
51.38%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 68.83% |
| Baxter International Inc | 38.27% |
| Globus Medical Inc | 56.77% |
| ResMed Inc | 58.57% |
| Integra Lifesciences Holdings Corp | 52.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.51% |
| Return on Assets | 5.40% |
| Return on Invested Capital | 6.54% |
| Profit Margin (Quarterly) | 9.79% |
| Operating Margin (Quarterly) | 14.96% |
| Return on Net Operating Assets | 6.81% |